Cargando…
A clinical perspective of the link between metabolic syndrome and hepatocellular carcinoma
Metabolic syndrome (MS), which is defined as a constellation of clinico-biological features closely related to insulin-resistance has reached epidemic levels in Western Europe and Northern America. Non-alcoholic fatty liver disease (NAFLD) represents the hepatic manifestation of MS. As its incidence...
Autores principales: | Cauchy, François, Belghiti, Jacques |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4918280/ https://www.ncbi.nlm.nih.gov/pubmed/27508191 http://dx.doi.org/10.2147/JHC.S44521 |
Ejemplares similares
-
Author response to: Comment on: Performance of non-invasive biomarkers compared with invasive methods for risk prediction of posthepatectomy liver failure in hepatocellular carcinoma
por: Hobeika, Christian, et al.
Publicado: (2022) -
Fibrolamellar hepatocellular carcinoma: current clinical perspectives
por: Lafaro, Kelly J, et al.
Publicado: (2015) -
Precision Medicine for Hepatocellular Carcinoma: Clinical Perspective
por: Galun, Danijel, et al.
Publicado: (2022) -
The Link between the Metabolic Syndrome and Cancer
por: Braun, Sandra, et al.
Publicado: (2011) -
The Link between NAFLD and Metabolic Syndrome
por: Radu, Fabiana, et al.
Publicado: (2023)